Search

Your search keyword '"Foo, Roger Sik-Yin"' showing total 140 results

Search Constraints

Start Over You searched for: Author "Foo, Roger Sik-Yin" Remove constraint Author: "Foo, Roger Sik-Yin"
140 results on '"Foo, Roger Sik-Yin"'

Search Results

1. Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma

2. A genomic enhancer signature associates with hepatocellular carcinoma prognosis

3. Integrative epigenomic and transcriptomic analyses reveal metabolic switching by intermittent fasting in brain

4. Trans-interaction of risk loci 6p24.1 and 10q11.21 is associated with endothelial damage in coronary artery disease

7. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer

8. Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy

9. Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer

10. Mitochondrial substrate utilization regulates cardiomyocyte cell-cycle progression

11. Supplementary Figure 1 from Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient–Derived Xenografts

12. Supplementary Table 1 from Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient–Derived Xenografts

13. Data from Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient–Derived Xenografts

14. Comprehensive molecular phenotyping ofARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities

15. A TWO-DECADE POPULATION-BASED STUDY ON THE EFFECT OF HYPERTENSION IN THE GENERAL POPULATION WITH OBESITY IN THE UNITED STATES

16. HEPATIC STEATOSIS AND ADVANCED HEPATIC FIBROSIS ARE INDEPENDENT PREDICTORS OF LONG-TERM MORTALITY IN ACUTE MYOCARDIAL INFARCTION

19. CTCF mediates the Activity-by-contact derived cis-regulatory hubs

20. BNIP‐2 Activation of Cellular Contractility Inactivates YAP for H9c2 Cardiomyoblast Differentiation (Adv. Sci. 31/2022)

21. Additional file 6 of Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma

22. Additional file 10 of Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma

23. Additional file 8 of Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma

24. Additional file 3 of Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma

26. Trans-interaction of risk loci 6p24.1 and 10q11.21 is associated with endothelial damage in coronary artery disease

27. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities

28. 11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial

29. 8-Oxoguanine DNA Glycosylase (OGG1) Deficiency Exacerbates Doxorubicin-Induced Cardiac Dysfunction

30. PREVALENCE AND OUTCOMES OF PATIENTS WITHOUT STANDARD MODIFIABLE RISK FACTORS FOLLOWING ACUTE CORONARY SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS

32. Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study

35. Integrative Epigenomic and High-Throughput Functional Enhancer Profiling Reveals Determinants of Enhancer Heterogeneity in Gastric Cancer

36. Effects of extended pharmacological disruption of zebrafish embryonic heart biomechanical environment on cardiac function, morphology, and gene expression

37. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities

38. Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities

39. Additional file 2 of Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer

40. Cohort profile: the Diet and Healthy Aging (DaHA) study in Singapore

41. A novel homozygous ALMS1 protein truncation mutation (c.2938dupA) revealed variable clinical expression among Saudi Alström syndrome patients

42. Integrative Epigenomic and Transcriptomic Analysis Reveals Robust Metabolic Switching in the Brain During Intermittent Fasting

46. Robust CTCF-Based Chromatin Architecture Underpins Epigenetic Changes in the Heart Failure Stress–Gene Response

47. Circles in the heart and cardiovascular system.

48. Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient–Derived Xenografts

49. The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma

Catalog

Books, media, physical & digital resources